STOK vs TJX · rev $15.6M vs P/E 32, rev $29.50B
Stoke Therapeutics Inc (STOK) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
STOK currently screens at market cap $1.88B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the STOK and TJX stock pages for the full models.
Not investment advice.